Cancer clinical trials in the region Centre-Val de Loire

111 currently recruiting clinical trials
Region Centre-Val de Loire

Early Access Liver and bile duct cancer
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic HER2 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
1 recruiting site
Jazz Pharmaceuticals
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
1 recruiting site
Merck Sharp & Dohme LLC
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
1 recruiting site
Astellas Pharma Développement mondial, Inc.
Early Access Kidney cancer Pancreas cancer
Clear cell carcinoma Neuroendocrine tumor Localized Von Hippel-Lindau syndrome (VHL)
1 recruiting site
Merck Sharp & Dohme LLC
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Janssen
Phase 3 Endometrial cancer #NCT07044336 #2024-518777-34-00
Locally Advanced Metastatic 1 2 Immunotherapy Chemotherapy
Systemic Treatment-Naive
13 recruiting sites
AstraZeneca
Phase 3 Lymphoma CLL & Richter's syndrome #NCT05254743 #2023-507699-38-00
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma None > 60 ml/min 50-60 ml/min 30-50 ml/min Other mutation None Systemic Treatment-Naive
10 recruiting sites
Loxo Oncology
Phase 3 Lymphoma #NCT06284122 #2023-505436-35-00
B cell lymphoma Follicular lymphoma 30-50 ml/min < 30 ml/min None Systemic Treatment-Naive
Allogeneic stem cell transplant Radiotherapy
37 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 3 Multiple myeloma #NCT05519085 #2023-509859-13-00
Symptomatic multiple myeloma Monoclonal component measurable 1 2 3 or more
Systemic Treatment-Naive
10 recruiting sites
Celgene